Rothstein B - Search Results

1

Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.

Casseres RG, Prussick L, Zancanaro P, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Au SC, Alomran A, Abdat R, Abudu M, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Casseres RG, et al. Among authors: rothstein b. J Am Acad Dermatol. 2020 Jun;82(6):1524-1526. doi: 10.1016/j.jaad.2020.02.005. Epub 2020 Feb 7. J Am Acad Dermatol. 2020. PMID: 32044410 Clinical Trial. No abstract available.

2

Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.

Prussick L, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Abdat R, Alomran A, Zancanaro P, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Prussick L, et al. Among authors: rothstein b. Br J Dermatol. 2019 Sep;181(3):609-611. doi: 10.1111/bjd.17822. Epub 2019 May 12. Br J Dermatol. 2019. PMID: 30801662 Clinical Trial. No abstract available.

3

Secukinumab for treating plaque psoriasis.

Rothstein B, Gottlieb A. Rothstein B, et al. Expert Opin Biol Ther. 2016;16(1):119-28. doi: 10.1517/14712598.2016.1121986. Epub 2015 Dec 14. Expert Opin Biol Ther. 2016. PMID: 26577956 Review.

4

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.

Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D. Rothstein B, et al. J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. doi: 10.1016/j.jaad.2017.02.049. Epub 2017 Apr 5. J Am Acad Dermatol. 2017. PMID: 28390737

5

Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.

Rothstein BE, McQuade B, Greb JE, Goldminz AM, Gottlieb AB. Rothstein BE, et al. J Drugs Dermatol. 2016 May 1;15(5):648-9. J Drugs Dermatol. 2016. PMID: 27168275

6

Direct and indirect patient costs of dermatology clinic visits and their impact on access to care and provider preference.

Rothstein BE, Gonzalez J, Cunningham K, Saraiya A, Dornelles AC, Nguyen BM. Rothstein BE, et al. Cutis. 2017 Dec;100(6):405-410. Cutis. 2017. PMID: 29360888

7

Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression.

Snedecor ER, Sung CC, Moncayo A, Rothstein BE, Mockler DC, Tonnesen MG, Jones EC, Fujita M, Clark RA, Shroyer KR, Chen J. Snedecor ER, et al. J Invest Dermatol. 2015 May;135(5):1456-1458. doi: 10.1038/jid.2015.22. Epub 2015 Jan 28. J Invest Dermatol. 2015. PMID: 25629424 Free PMC article. No abstract available.

8

Well-differentiated squamous cell carcinoma as a complication of the 1927-nm thulium nonablative fractional laser.

Rothstein BE, Cohen JL. Rothstein BE, et al. J Cosmet Dermatol. 2020 Dec;19(12):3417-3419. doi: 10.1111/jocd.13796. Epub 2020 Oct 29. J Cosmet Dermatol. 2020. PMID: 33118281 No abstract available.

9

Practice Variation in Utilization of Flap or Graft Reconstruction Among Veterans Affairs Surgeons After Extirpation of Keratinocyte Carcinoma on the Nose.

Massey PR, Rothstein BE, Gupta S, Sigel K, Schmults CD, Waldman A. Massey PR, et al. Among authors: rothstein be. Dermatol Surg. 2021 Sep 1;47(9):1220-1223. doi: 10.1097/DSS.0000000000003124. Dermatol Surg. 2021. PMID: 34238788

10

An Updated Work-Up for Patients With Xanthelasma Palpebrarum.

Rothstein BE, Cohen JL. Rothstein BE, et al. Dermatol Surg. 2021 Aug 1;47(8):1170-1171. doi: 10.1097/DSS.0000000000003078. Dermatol Surg. 2021. PMID: 33988552 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page